AAAAAA

   
Results: 1-3 |
Results: 3
INFLUENCE OF GOSERELIN DEPOT THERAPY ON EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN PELVIC ENDOMETRIOSIS
Authors: DILIETO A DEROSA G ALBANO G STAIBANO S CAMPANILE M PONTILLO M GALLO F MICALEF R PALADINI A
Citation: A. Dilieto et al., INFLUENCE OF GOSERELIN DEPOT THERAPY ON EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN PELVIC ENDOMETRIOSIS, Gynecological endocrinology, 11(1), 1997, pp. 17-20
DESOGESTREL VERSUS GESTODENE IN ORAL-CONTRACEPTIVES - INFLUENCE ON THE CLINICAL AND HISTOMORPHOLOGICAL FEATURES OF BENIGN BREAST-DISEASE (VOL 55, PG 71, 1994)
Authors: DILIETO A DEROSA G ALBANO G PAGNANO AM CAMPANILE M TERRACCIANO L PONTILLO M CIMMINO E COVELLI A PALADINI A
Citation: A. Dilieto et al., DESOGESTREL VERSUS GESTODENE IN ORAL-CONTRACEPTIVES - INFLUENCE ON THE CLINICAL AND HISTOMORPHOLOGICAL FEATURES OF BENIGN BREAST-DISEASE (VOL 55, PG 71, 1994), European journal of obstetrics, gynecology, and reproductive biology, 58(1), 1995, pp. 101-101
DESOGESTREL VERSUS GESTODENE IN ORAL-CONTRACEPTIVES - INFLUENCE ON THE CLINICAL AND HISTOMORPHOLOGICAL FEATURES OF BENIGN BREAST DISEASE
Authors: DILIETO A DEROSA G ALBANO G PAGNANO AM CAMPANILE M TERRACCIANO L PONTILLO M CIMMINO E COVELLI A PALADINI A
Citation: A. Dilieto et al., DESOGESTREL VERSUS GESTODENE IN ORAL-CONTRACEPTIVES - INFLUENCE ON THE CLINICAL AND HISTOMORPHOLOGICAL FEATURES OF BENIGN BREAST DISEASE, European journal of obstetrics, gynecology, and reproductive biology, 55(1), 1994, pp. 73-85
Risultati: 1-3 |